|
1
|
Kotsiri I, Resta P, Spyrantis A,
Panotopoulos C, Chaniotis D, Beloukas A and Magiorkinis E: Viral
infections and schizophrenia: A comprehensive review. Viruses.
15(1345)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maisarah A, Mohamad S, Husain M, Abdullah
S and Noordin R: Association between infection with Toxoplasma
gondii and psychiatric disorders. Folia Parasitol (Praha).
69(2022.008)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kim K and Weiss LM: Toxoplasma: The
next 100 years. Microbes Infect. 10:978–984. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bisetegn H, Debash H, Ebrahim H, Mahmood
N, Gedefie A, Tilahun M, Alemayehu E, Mohammed O and Feleke DG:
Global seroprevalence of Toxoplasma gondii infection among
patients with mental and neurological disorders: A systematic
review and meta-analysis. Health Sci Rep. 6(e1319)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Flegr J: Effects of Toxoplasma on
human behavior. Schizophr Bull. 33:757–760. 2007.
|
|
6
|
Horacek J, Flegr J, Tintera J, Verebova K,
Spaniel F, Novak T, Brunovsky M, Bubenikova-Valesova V, Holub D,
Palenicek T and Höschl C: Latent toxoplasmosis reduces gray matter
density in schizophrenia but not in controls:
Voxel-based-morphometry (VBM) study. World J Biol Psychiatry.
13:501–509. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shapiro K, Bahia-Oliveira L, Dixon B,
Dumètre A, De Wit LA, VanWormer E and Villena I: Environmental
transmission of Toxoplasma gondii: Oocysts in water, soil
and food. Food Waterborne Parasitol. 15(e00049)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Achaw B, Tesfa H, Zeleke AJ, Worku L,
Addisu A, Yigzaw N and Tegegne Y: Sero-prevalence of Toxoplasma
gondii and associated risk factors among psychiatric
outpatients attending University of Gondar Hospital, Northwest
Ethiopia. BMC Infect Dis. 19(581)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Teimouri A, Nassrullah OJ, Hedayati P,
Bahreini MS, Alimi R, Mohtasebi S, Salemi AM and Asgari Q:
Prevalence and predictors of Toxoplasma gondii infection in
psychiatric inpatients in Fars Province, Southern Iran. Front
Psychiatry. 13(891603)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
S. Al-Malki E: Toxoplasmosis: stages of
the protozoan life cycle and risk assessment in humans and animals
for an enhanced awareness and an improved socio-economic status.
Saudi J Biol Sci. 28:962–969. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin
WC, Fan CK, Fang CT and Ji DD: Seroepidemiology of Toxoplasma
gondii infection among healthy blood donors in Taiwan. PLoS
One. 7(e48139)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stepanova EV, Kondrashin AV, Sergiev VP,
Morozova LF, Turbabina NA, Maksimova MS, Romanov DV, Kinkulkina MA,
Lazareva AV and Morozov EN: Toxoplasmosis and mental disorders in
the Russian Federation (with special reference to schizophrenia).
PLoS One. 14(e0219454)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
McAuley JB: Congenital toxoplasmosis. J
Pediatric Infect Dis Soc. 3 (Suppl 1):S30–S35. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
McLeod R, Lykins J, Gwendolyn Noble A,
Rabiah P, Withers S, Clouser F and Boyer K: Management of
congenital toxoplasmosis. Curr Pediatr Rep. 2:166–194. 2014.
|
|
15
|
Kim K and Weiss LM: Toxoplasma
gondii: The model apicomplexan. Int J Parasitol. 34:423–432.
2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Weiss LM and Kim K: The development and
biology of bradyzoites of Toxoplasma gondii. Front Biosci.
5:D391–D405. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Grada S, Mihu AG, Petrescu C, Suciu O,
Marincu I, Lupu MA and Olariu TR: Toxoplasma gondii
Infection in patients with psychiatric disorders from Western
Romania. Medicina (Kaunas). 58(208)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ahmad D, Mehdi S, Sayed HH, Sayed AK and
Shirzad G: Serological survey of Toxoplasma gondii in
schizophrenia patients referred to Psychiatric Hospital, Sari City,
Iran. Trop Biomed. 27:476–482. 2010.PubMed/NCBI
|
|
19
|
Alvarado-Esquivel C, Urbina-Álvarez JD,
Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G,
Liesenfeld O and Dubey JP: Toxoplasma gondii infection and
schizophrenia: A case control study in a low Toxoplasma
seroprevalence Mexican population. Parasitol Int. 60:151–155.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McConkey GA, Martin HL, Bristow GC and
Webster JP: Toxoplasma gondii infection and
behaviour-location, location, location? J Exp Biol. 216:113–119.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu S: Psychosis may be associated with
toxoplasmosis. Med Hypotheses. 73:799–801. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Torrey EF and Yolken RH: Schizophrenia as
a pseudogenetic disease: A call for more gene-environmental
studies. Psychiatry Res. 278:146–150. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Buentello E: Preliminary report on the
relations between toxoplasmosis, lysergic acid & schizophrenia.
Gac Med Mex. 88:693–710. 1958.PubMed/NCBI(In Spanish).
|
|
24
|
Chorlton SD: Toxoplasma gondii and
schizophrenia: A review of published RCTs. Parasitol Res.
116:1793–1799. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Amouei A, Moosazadeh M, Nayeri Chegeni T,
Sarvi S, Mizani A, Pourasghar M, Hosseini Teshnizi S, Hosseininejad
Z, Dodangeh S, Pagheh A, et al: Evolutionary puzzle of
Toxoplasma gondii with suicidal ideation and suicide
attempts: An updated systematic review and meta-analysis.
Transbound Emerg Dis. 67:1847–1860. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de Barros JLVM, Barbosa IG, Salem H, Rocha
NP, Kummer A, Okusaga OO, Soares JC and Teixeira AL: Is there any
association between Toxoplasma gondii infection and bipolar
disorder? A systematic review and meta-analysis. J Affect Disord.
209:59–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Prandovszky E, Gaskell E, Martin H, Dubey
JP, Webster JP and McConkey GA: The neurotropic parasite
Toxoplasma gondii increases dopamine metabolism. PLoS One.
6(e23866)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Henriquez SA, Brett R, Alexander J, Pratt
J and Roberts CW: Neuropsychiatric disease and Toxoplasma
gondii infection. Neuroimmunomodulation. 16:122–133.
2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gaskell EA, Smith JE, Pinney JW, Westhead
DR and McConkey GA: A unique dual activity amino acid hydroxylase
in Toxoplasma gondii. PLoS One. 4(e4801)2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Berdoy M, Webster JP and Macdonald DW:
Fatal attraction in rats infected with Toxoplasma gondii.
Proc Biol Sci. 267:1591–1594. 2000.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Celik T, Kartalci S, Aytas O, Akarsu GA,
Gozukara H and Unal S: Association between latent toxoplasmosis and
clinical course of schizophrenia-continuous course of the disease
is characteristic for Toxoplasma gondii-infected patients.
Folia Parasitol (Praha). 62(2015.015)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Parlog A, Schlüter D and Dunay IR:
Toxoplasma gondii-induced neuronal alterations. Parasite
Immunol. 37:159–170. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Parlog A, Harsan LA, Zagrebelsky M, Weller
M, von Elverfeldt D, Mawrin C, Korte M and Dunay IR: Chronic murine
toxoplasmosis is defined by subtle changes in neuronal
connectivity. Dis Model Mech. 7:459–469. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
David CN, Frias ES, Szu JI, Vieira PA,
Hubbard JA, Lovelace J, Michael M, Worth D, McGovern KE, Ethell IM,
et al: GLT-1-dependent disruption of CNS glutamate homeostasis and
neuronal function by the protozoan parasite Toxoplasma
gondii. PLoS Pathog. 12(e1005643)2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xiao J, Prandovszky E, Kannan G, Pletnikov
MV, Dickerson F, Severance EG and Yolken RH: Toxoplasma
gondii: Biological parameters of the connection to
schizophrenia. Schizophr Bull. 44:983–992. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mitra R, Sapolsky RM and Vyas A:
Toxoplasma gondii infection induces dendritic retraction in
basolateral amygdala accompanied by reduced corticosterone
secretion. Dis Model Mech. 6:516–520. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rantala MJ, Luoto S, Borráz-León JI and
Krams I: Schizophrenia: The new etiological synthesis. Neurosci
Biobehav Rev. 142(104894)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Abdoli A: Toxoplasma gondii and
neuropsychiatric diseases: Strain hypothesis. Neurol Sci.
34:1697–1698. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kano SI and Sawa A: Reply to Brune M and
Theiss C: Remaining questions in the relationship between T.
gondii infection and major mental illness. Mol Psychiatry.
25:4–5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Evans AK, Strassmann PS, Lee IP and
Sapolsky RM: Patterns of Toxoplasma gondii cyst distribution
in the forebrain associate with individual variation in predator
odor avoidance and anxiety-related behavior in male long-evans
rats. Brain Behav Immun. 37:122–133. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Afonso C, Paixão VB and Costa RM: Chronic
Toxoplasma infection modifies the structure and the risk of
host behavior. PLoS One. 7(e32489)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goodwin DG, Strobl JS and Lindsay DS:
Evaluation of five antischizophrenic agents against Toxoplasma
gondii in human cell cultures. J Parasitol. 97:148–151.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Leweke FM, Gerth CW, Koethe D,
Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF and Yolken
RH: Antibodies to infectious agents in individuals with recent
onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 254:4–8.
2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Webster JP, Lamberton PHL, Donnelly CA and
Torrey EF: Parasites as causative agents of human affective
disorders? The impact of anti-psychotic, mood-stabilizer and
anti-parasite medication on Toxoplasma gondii's ability to
alter host behaviour. Proc Biol Sci. 273:1023–1030. 2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shibre T, Alem A, Abdulahi A, Araya M,
Beyero T, Medhin G, Deyassa N, Negash A, Nigatu A, Kebede D and
Fekadu A: Trimethoprim as adjuvant treatment in schizophrenia: A
double-blind, randomized, placebo-controlled clinical trial.
Schizophr Bull. 36:846–851. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Dickerson F, Boronow J, Stallings C,
Origoni A and Yolken R: Toxoplasma gondii in individuals
with schizophrenia: Association with clinical and demographic
factors and with mortality. Schizophr Bull. 33:737–740.
2007.PubMed/NCBI View Article : Google Scholar
|
